This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
T Asami , H Yamasue , F Hayano , M Nakamura , (2009). Sexually dimorphic gray matter volume reduction in patients with panic disorder. Psychiatry Research 173, 128–134.
AL Brody , S Saxena , MA Mandelkern , LA Fairbanks , (2001). Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biological Psychiatry 50, 171–178.
S Campbell , G MacQueen (2006). An update on regional brain volume differences associated with mood disorders. Current Opinion in Psychiatry 19, 25–33.
JA Crippa , AW Zuardi (2006). Duloxetine in the treatment of panic disorder. International Journal of Neuropsychopharmacology 9, 633–634.
RS Duman (2004). Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Medicine 5, 11–25.
A Etkin , C Pittenger , HJ Polan , ER Kandel (2005). Toward a neurobiology of psychotherapy: basic science and clinical applications. Journal of Neuropsychiatry and Clinical Neuroscience 17, 145–158.
A Floel , R Ruscheweyh , K Kruger , C Willemer , (2010). Physical activity and memory functions: are neurotrophins and cerebral gray matter volume the missing link? Neuroimage 49, 2756–2763.
JE Frampton , GL Plosker (2007). Duloxetine: a review of its use in the treatment of major depressive disorder. CNS Drugs 21, 581–609.
TS Frodl , N Koutsouleris , R Bottlender , C Born , (2008 b). Depression-related variation in brain morphology over 3 years: effects of stress? Archives of General Psychiatry 65, 1156–1165.
PC Guest , MR Knowles , S Molon-Noblot , K Salim , (2004). Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling. Brain Research 1002, 1–10.
JP Hamilton , M Siemer , IH Gotlib (2008). Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Molecular Psychiatry 13, 993–1000.
RC Kessler , PE Stang , HU Wittchen , TB Ustun , (1998). Lifetime panic-depression comorbidity in the National Comorbidity Survey. Archives of General Psychiatry 55, 801–808.
M Kodama , T Fujioka , RS Duman (2004). Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biological Psychiatry 56, 570–580.
PC Koolschijn , NE van Haren , GJ Lensvelt-Mulders , HE Hulshoff Pol , (2009). Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Human Brain Mapping 30, 3719–3735.
J Kornhuber , M Reichel , P Tripal , TW Groemer , (2009). The role of ceramide in major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience 259 (Suppl. 2), S199–S204.
H Lavretsky , DJ Roybal , M Ballmaier , AW Toga , (2005). Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. Journal of Clinical Psychiatry 66, 964–967.
CT Li , CP Lin , KH Chou , IY Chen , (2010). Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. NeuroImage 50, 347–356.
PJ Magistretti (2000). Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling. Brain Research 886, 108–112.
W Maier , J Minges , D Lichtermann (1995). The familial relationship between panic disorder and unipolar depression. Journal of Psychiatric Research 29, 375–388.
H Manev , T Uz , R Manev (2003). Glia as a putative target for antidepressant treatments. Journal of Affective Disorders 75, 59–64.
C Mannari , N Origlia , A Scatena , A Del Debbio , (2008). BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. Cellular and Molecular Neurobiology 28, 457–468.
S Mannuzza , TF Chapman , DF Klein , AJ Fyer (1994). Familial transmission of panic disorder: effect of major depression comorbidity. Anxiety 1, 180–185.
G Massana , JM Serra-Grabulosa , P Salgado-Pineda , C Gasto , (2003). Parahippocampal gray matter density in panic disorder: a voxel-based morphometric study. American Journal of Psychiatry 160, 566–568.
HS Mayberg , SK Brannan , JL Tekell , JA Silva , (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 48, 830–843.
HS Mayberg , AM Lozano , V Voon , HE McNeely , (2005). Deep brain stimulation for treatment-resistant depression. Neuron 45, 651–660.
HS Mayberg , JA Silva , SK Brannan , JL Tekell , (2002). The functional neuroanatomy of the placebo effect. American Journal of Psychiatry 159, 728–737.
RC Oldfield (1971). The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9, 97–113.
DG Perahia , YL Pritchett , DK Kajdasz , M Bauer , (2008). A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Journal of Psychiatry Research 42, 22–34.
N Perroud , KJ Aitchison , R Uher , R Smith , (2009). Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology 34, 2517–2528.
ML Phillips , WC Drevets , SL Rauch , R Lane (2003). Neurobiology of emotion perception II: implications for major psychiatric disorders. Biological Psychiatry 54, 515–528.
SS Pillay , DA Yurgelun-Todd , CM Bonello , B Lafer , (1997). A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity. Biological Psychiatry 42, 79–84.
X Protopopescu , H Pan , O Tuescher , M Cloitre , (2006). Increased brainstem volume in panic disorder: a voxel-based morphometric study. Neuroreport 17, 361–363.
PP Roy-Byrne , P Stang , HU Wittchen , B Ustun , (2000). Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. British Journal of Psychiatry 176, 229–235.
Y Sakai , H Kumano , M Nishikawa , Y Sakano , (2005). Cerebral glucose metabolism associated with a fear network in panic disorder. Neuroreport 16, 927–931.
NM Simon , RE Kaufman , EA Hoge , JJ Worthington , (2009). Open-label support for duloxetine for the treatment of panic disorder. CNS Neuroscience & Therapeutics 15, 19–23.
T Sobanski , G Wagner , G Peikert , U Gruhn , (2010). Temporal and right frontal lobe alterations in panic disorder: a quantitative volumetric and voxel-based morphometric MRI study. Psychological Medicine. Published online: 8 January 2010. doi:10.1017/S0033291709991930.
D Souery , P Oswald , I Massat , U Bailer , (2007). Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. Journal of Clinical Psychiatry 68, 1062–1070.
E Szadoczky , J Vitrai , Z Rihmer , J Furedi (2000). Suicide attempts in the Hungarian adult population. Their relation with DIS/DSM-III-R affective and anxiety disorders. European Psychiatry 15, 343–347.
AG Thomas , S Marrett , ZS Saad , DA Ruff , (2009). Functional but not structural changes associated with learning: an exploration of longitudinal voxel-based morphometry (VBM). NeuroImage 48, 117–125.
RR Uchida , CM Del-Ben , GF Busatto , FL Duran , (2008). Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Research 163, 21–29.
N Vasic , H Walter , A Hose , RC Wolf (2008). Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: a voxel-based morphometry study. Journal of Affective Disorders 109, 107–116.
P Videbech , B Ravnkilde (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 161, 1957–1966.
M Vythilingam , E Vermetten , GM Anderson , D Luckenbaugh , (2004). Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biological Psychiatry 56, 101–112.
JM Witkin , GJ Marek , BG Johnson , DD Schoepp (2007). Metabotropic glutamate receptors in the control of mood disorders. CNS Neurological Disorders and Drug Targets 6, 87–100.
HK Yoo , MJ Kim , SJ Kim , YH Sung , (2005). Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. European Journal of Neuroscience 22, 2089–2094.
K Yucel , M McKinnon , R Chahal , V Taylor , (2009). Increased subgenual prefrontal cortex size in remitted patients with major depressive disorder. Psychiatry Research 173, 71–76.